Format
Sort by

Send to

Choose Destination

Search results

Items: 8

1.

Prion diseases and adult neurogenesis: how do prions counteract the brain's endogenous repair machinery?

Relaño-Ginés A, Lehmann S, Crozet C.

Prion. 2014;8(3):240-6. Epub 2014 May 15.

2.

Elements modulating the prion species barrier and its passage consequences.

Torres JM, Espinosa JC, Aguilar-Calvo P, Herva ME, Relaño-Ginés A, Villa-Diaz A, Morales M, Parra B, Alamillo E, Brun A, Castilla J, Molina S, Hawkins SA, Andreoletti O.

PLoS One. 2014 Mar 7;9(3):e89722. doi: 10.1371/journal.pone.0089722. eCollection 2014.

3.

Systemic delivery of siRNA down regulates brain prion protein and ameliorates neuropathology in prion disorder.

Lehmann S, Relano-Gines A, Resina S, Brillaud E, Casanova D, Vincent C, Hamela C, Poupeau S, Laffont M, Gabelle A, Delaby C, Belondrade M, Arnaud JD, Alvarez MT, Maurel JC, Maurel P, Crozet C.

PLoS One. 2014 Feb 14;9(2):e88797. doi: 10.1371/journal.pone.0088797. eCollection 2014.

4.

Prion replication occurs in endogenous adult neural stem cells and alters their neuronal fate: involvement of endogenous neural stem cells in prion diseases.

Relaño-Ginès A, Gabelle A, Hamela C, Belondrade M, Casanova D, Mourton-Gilles C, Lehmann S, Crozet C.

PLoS Pathog. 2013;9(8):e1003485. doi: 10.1371/journal.ppat.1003485. Epub 2013 Aug 1.

5.

Stem cell therapy extends incubation and survival time in prion-infected mice in a time window-dependant manner.

Relaño-Ginés A, Lehmann S, Bencsik A, Herva ME, Torres JM, Crozet CA.

J Infect Dis. 2011 Oct 1;204(7):1038-45. doi: 10.1093/infdis/jir484.

6.

Prion infection of differentiated neurospheres.

Herva ME, Relaño-Ginés A, Villa A, Torres JM.

J Neurosci Methods. 2010 May 15;188(2):270-5. doi: 10.1016/j.jneumeth.2010.02.022. Epub 2010 Mar 3.

PMID:
20206206
7.

Gene and cell therapy for prion diseases.

Relaño-Ginés A, Gabelle A, Lehmann S, Milhavet O, Crozet C.

Infect Disord Drug Targets. 2009 Feb;9(1):58-68. Review.

PMID:
19200016
8.

The proximal promoter region of mTert is sufficient to regulate telomerase activity in ES cells and transgenic animals.

Pericuesta E, Ramírez MA, Villa-Diaz A, Relaño-Gines A, Torres JM, Nieto M, Pintado B, Gutiérrez-Adán A.

Reprod Biol Endocrinol. 2006 Feb 3;4:5.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk